Takeda Teams Up with Code in $2B Rare Disease Pact
Summary – Takeda and Code Biotherapeutics announced a collaboration agreement to leverage the latter’s proprietary targeted 3DNA® non-viral genetic medicine delivery platform…
Summary – Takeda and Code Biotherapeutics announced a collaboration agreement to leverage the latter’s proprietary targeted 3DNA® non-viral genetic medicine delivery platform…
Summary – Of course, Xiaomi is not far behind, they too have similar offerings (and they have smart shoes) and the latest…
Synopsis: Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and…
Synopsis : Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced plans to expand its commercial network across…
Summary : Recipharm, a global contract development and manufacturing organisation (CDMO), is continuing to build its service offerings in new biologic modalities…
Synopsis : Recipharm, a leading global contract development and manufacturing organisation (CDMO), announced the acquisition of Arranta Bio, a prominent advanced therapy…
Summary – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Medigene AG (FSE: MDG1, Prime Standard, “Medigene”), a clinical-stage immuno-oncology company focusing on the…
Synopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale…
Summary : After a long wait, Bharat Biotech’s Covaxin has finally got the nod from the US Food and Drug Administration (USFDA)…
Summary : Takeda Pharmaceuticals was the top Future of Work innovator in the pharmaceutical sector in the last quarter. Research and innovation…